Sunday, March 21 2010 chengcm@ctihk.com Companies featured in the current edition of the newsletter: ACTC, ENZ, IMUC, IWEB, MCLN, NWCI, NXOI, PSID The markets closed out the week on a mostly positive note.The Dow was the big winner last week, closing out Friday at10,742, up 117 points, or 1.1%, from last week.The Dow has now been up for nineconsecutive days and is up 1.5% for the year. The NASDAQ made gains last week as well, ending at 2374, 7points, or 0.28%, higher than the week prior, and up 2.9% since the beginning of the year. The S&P 500 closed out the week at 1160, up 10 points and 2.4% for the year. Rounding out the major indices, the Russell 2000 ended the week on a down note, dropping 2.8 points to close the week at 674, 0.4% lower than the week before, but up 5.3% on the year..

Unemployment data for last week were a mixed bag, indicating a slowdown in labor market improvements. Initial jobless claims dropped by 5,000 from last week to 457,000, well below the year-ago level of 644,000. However, continuing claims were up 12,000 to 4.58 million, from 4.52 million last week.

A few companies of note will announce earnings this week. KB Home (NYSE: KBH) will reveal its numbers Tuesday before the bell, with Adobe (NASDAQ: ADBE) and Darden Restaurants (NYSE: DRI) announcing after the bell. Best Buy (NYSE: BBY) announces its earnings Thursday morning. Oracle (NASDAQ: ORCL) will make its announcements after the close of market Thursday.

A fairly quiet economic calendar begins Tuesday with Existing Home Sales for February announced at 10:00am, followed by Durable Orders Wednesday at 8:30am. New Home Sales and weekly crude inventories will also be announced on Wednesday, at 10:00am and 10:30, respectively. Initial and Continuing unemployment Claims will be announced Thursday at 8:30am. Friday, the third GDP estimate for Q4 is announced at 8:30am, and the final University of Michigan Consumer Sentiment report at 9:55am.

A light conference schedule begins Monday with the 37th Annual Howard Weil Energy Conference in New Orleans. On Tuesday, the Sidoti & Company Emerging Growth Institutional Investors Forum begins in San Francisco. Barclay`s will host its 2010 Global Healthcare Conference in Miami, Florida. The two-day Commercial & Industrial Conference hosted by BB&T Capital Markets begins Thursday in New York.

Enzo Biochem, Inc. (NYSE: ENZ)said last week it entered into an agreement with MultiGEN Diagnostics Inc., of San Diego, California, for exclusive rights to market MultiGENs unique diagnostic tests based on multiplex DNA sequencing, in the state of New York. In addition, Enzo has been granted marketing rights for other non-exclusive territories in United States. The company also announced a supply and distribution agreement between EnzoLifeSciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research. This agreement covers Enzos proprietary fluorescent dye labels for increasing signal intensity in labeling nucleic acids. Shares of ENZ closed at $5.98, down $0.25, or 4%. It is 5.5% for the year.

PositiveID Corporation (NASDAQ:PSID)announced that it had published a white paper entitled Fixing the Black Hole in Diabetes Management, which describes the health and economic burden of diabetes on Americans and our economy. The paper details how patient care and overall health improves when there is a high quality of patient-clinician collaboration. Moreover, it finds that even diabetics who follow recommended self-monitoring blood glucose (SMBG) testing level guidelines may not share the test results with their healthcare providers. The test results are not being used to improve glycemic control and achieve long-term goals, thus getting lost in a black hole. Shares of PSID closed at $1.54, up $0.01, or 0.65%. It is up 38.7% for the year.

Advanced Cell Technology, Inc. (OTCBB:ACTC)said last week it filed its Annual Report with the Securities and Exchange Commission for the period ended December 31, 2009 on Form 10-K. The company had a strong year, and achieved a number of milestones. The company received an unqualified opinion from its independent auditor that it has sufficient capital to fund its clinical development and other operating activities for at least the next 12 months. It was also approved for relisting on the OTCBB, where it received funding that strengthened its balance sheet, and reached a key debt restructuring agreement with debenture holders. The company also made progress in its research efforts, including being granted Orphan Drug Status by the FDA for a treatment for Stargardts disease and discovering new findings regarding the potential of hemangioblasts (human progenitor cells) as a treatment for human vascular disease. In other news, last week Liberty Analytics initiated independent research coverage on ACTC. Shares of ACTC closed at $0.103, up 3.2%. It is unchanged on the year.

NewCardio, Inc., (OTCBB: NWCI), a cardiac diagnostic technology provider, announced that a U.S.-based CRO that provides early phase and specialty clinical drug development services to the pharmaceutical industry, has signed an MSA, licensing NewCardio`s QTinno software solution in order to deliver fully automated cardiac safety analysis in early phase QT studies. In addition, the CRO has signed a services work order, including standard operating procedures (SOP) and validation kits, as well as professional services, in order to accelerate its readiness for delivering ECG core lab services to its sponsor customers. Shares of NWCI closed at $1.39, down $0.03, or 2.1%. It is up an impressive 93.1% for the year.

ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC), a biotechnology company developing immune based therapies for the treatment of various forms of cancer, announced it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the companys proprietary intellectual property for ICT-109 and ICT-37, two of the companys monoclonal antibody product candidates. Shares of IMUC remained unchanged at $1.00. It is up 1% for the year.

MedClean Technologies, Inc., (OTCBB: MCLN), the leading provider of onsite technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, announced the expansion of its MedClean Container/Mobile Series product line designed to increase the company`s market opportunity. With the introduction of the MedClean 4100/MC4200 the company is now positioned to expand its market share by providing packaged solutions and value-based pricing to a broader market. Shares of MCLN closed at $0.019, down $0.001, or 5%. It is down 36.7% for the year.

Volume Alert:Shares of Next One Interactive, Inc. (OTCBB: NXOI) surged 43.5%, from $0.69, to $0.99, on almost twice the average volume. NXOI has released some intriguing details about the companys current state and future plans in recent weeks, and the dramatic rise in price last week could be an indication that investors are taking note of the companys earning potential.

IceWEB, Inc. (OTCBB: IWEB), a leading provider of Unified Data Storage and secure building blocks for cloud storage networks, announced that the companys Iplicity Cloud Storage Appliance now fully incorporates both Internet Protocol Security (IPSEC) secure access capabilities and AES-256 Volume Encryption. Shares of IWEB closed at $0.165, up $0.005, or 3.1%. It is up 17.9% for the year.

A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. THE READER SHOULD VERIFY ALL CLAIMS AND DO ITS OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. This publication accepts compensation from companies that it features. This newsletter should not be regarded as an independent publication. Our editors may, from time to time, acquire positions in the companies that they cover. This could represent a conflict of interest. The CEOcast newsletter shall be under no obligation to inform readers about its trading activities. CEOcast`s editors reserve the right to buy or sell shares in these companies at any time. The following companies, featured in this newsletter, have compensated CEOcast: Advanced Cell Technology, seven thousand five hundred dollars per month, plus warrants to purchase up to fifteen million shares of stock, iceWEB, seven thousand five hundred dollars per month in cash, plus seven thousand five hundred dollars in stock per month for a six-month agreement, PositiveID Corporation, seven thousand five hundred dollars per month, NewCardio, seven thousand five hundred dollars per month and two hundred thousand shares of stock for a six-month agreement, ImmunoCellular Therapeutics, twelve thousand five hundred dollars per month, MedClean Technologies, seven thousand five hundred dollars per month and six million shares for a one-year agreement, Enzo Biochem, seventeen thousand dollars per month, NewCardio, seven thousand five hundred dollars per month and two hundred thousand shares of stock for a six-month agreement.

UNSUBSCRIBE You can either

ACTC · ADBE · IMUC · IPSEC · IWEB · MCLN · NWCI · NXOI · ORCL · PSID · SMBG

Monday, March 15 2010 wishnine@aol.com Companies featured in the current edition of the newsletter: ACTC, CVM, ENZ, HYTM, IMUC, IWEB, OMCM, MFGD, NWCI, NXOI, PHC, SRCO, XSNX The markets had another strong showing last week, as all of the major indices were up again. The Dow rose 0.55%, or 59points to end the week at 10625. The Nasdaq also gained last week, increasing its total by 41points, or 1.78% to close at 2368. The S&P 500 climbed up 11points, or 1%, closing at 1150. The Russell 2000 followed in its big brothers footsteps, adding 11points to close out the week 1.6% higher at 677.

Snowstorms didnt stop U.S. consumers from spending their money at their favorite retailers. Retail sales for February rose 0.3%, beating predictions of a 0.2% increase. The U.S. trade balance posted a smaller than expected increase,coming in at -37.3B.Wholesale Inventories fell 0.2%, which economists say is likely an indication thatthe period of massive inventory liquidation is over. Business inventories were flat, although up from a 0.3% drop in December. The consumer sentiment index failed to meet economists expectations again this month, dropping to 72.5 versus an expected rise to 74.

With no companies of note scheduled to announce earnings, the focus again this week will be on economic data reports, although reports are somewhat sparse themselves. January Existing Home Sales will be reported at 10:00am Tuesday, followed by Durable Orders and New Home Sales on Wednesday at 8:30am and 10:00am, respectively. Weekly crude inventories come in on Wednesday as well at 10:30am. Initial and Continuing Unemployment Claims for the week ended March 6th will be announced Thursday morning at 8:30am.

The conference schedule kicks off Monday with the 22nd Annual OC Growth Stock Conference presented by Roth in Dana Point, CA., and the start of the UBS West Coast Life Sciences Bus Tour. Money4Gold (OTCBB: MFGD) will present on Tuesday at the Roth Conference at 5:30 pm Pacific time, while Hythiam (OTCBB: HYTM) will present the following morning at 9:30 am. The Goldman Sachs Industrials Unscripted Conference in Boston begins on Tuesday, as does the two-day Jefferies Global Cleantech Conference in New York. JPMorgan will hold their Gaming, Lodging, Restaurant & Leisure Conference in Las Vegas on Wednesday, which also marks the start of the Credit Suisse Transportation Small/Mid Cap Conference in Boston. The CL King West Coast Best Ideas Conference begins Thursday in San Francisco.

Enzo Biochem, Inc. (NYSE: ENZ)announced its earnings results for its second fiscal quarter ended January 31, 2010. ENZ reported an increase in total operating revenue of 11% to $23.2 million, with both operating units Enzo Clinical Labs and Enzo Life Sciences gaining on the year. Gross profit advanced 36%, to $10.9 million, with gross margin increasing 24% to 47% from 38% in the year ago quarter. Shares of ENZ closed at $6.23, up $0.24, or 4%.

CEL-SCI Corporation(AMEX: CVM)announced last week that it had received a$125,000payment from Byron Biopharma under its licensing agreement where CEL-SCI granted Byron an exclusive license to market and distribute the company`s cancer drug Multikine in the Republic ofSouth Africa (the Territory). CEL-SCI already has existing licensing agreements for Multikine with Teva Pharmaceuticals ofIsraeland Orient Europharma ofTaiwanin other countries. CEL-SCI plans to keep the European and US marketing rights for the Multikine head and neck cancer indication in-house. Under the agreement, Byron will also be responsible for registering the product in the territory. Once Multikine has been approved for sale, CEL-SCI will be responsible for manufacturing the product, while Byron will be responsible for sales in the area. Revenues will be split 50/50 between CEL-SCI and Byron. Shares of CVM closed at $0.72, up $0.08, or 12.5%.

Volume Alert:Shares of healthcare services company PHC, Inc.,(AMEX: PHC) surged 5.1% last week on more than five times average volume, as investors identified the company as a potential acquisition candidate after Psychiatric Solutions, a larger healthcare services company focused on the treatment of addiction, surged 25% after it said it received an unsolicited proposal to be acquired. Companies may be targeting acquisitions in the addiction treatment area as a result of favorable legislation that requires healthcare providers to treat mental and physical illnesses the same way, which is likely to increase reimbursement for addiction. The company also said that it expects its recently opened ten-bed adolescent unit at its Seven Hills Behavioral Institute (SHBI) in Henderson, Nevada to generate $2 million in annual revenue and strong operating margins, which are expected to generate an incremental 3 cents per share in annual earnings. Shares of PHC closed at $1.45, up $0.07.

Advanced Cell Technology, Inc. (OTCBB:ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine,said that company Chairman and Chief Executive Officer William M. Caldwell IV was interviewed on Bloomberg Radio`s popular mid-day program, The Hays Advantage, hosted by Kathleen Hays, last week. The discussion covered Advanced Cells retinal pigment epithelium (RPE) cell program for the treatment of Stargardts disease and age-related macular degeneration (AMD), the leading cause of blindness in Americans over 60 years of age, as well as the size of the potential market for an embryonic stem cell-based cure for AMD. Shares of ACTC closed at $0.0998, down $0.0002, or 0.2%.

XsunX, Inc.(OTCBB: XSNX), the developer of advanced, thin-film photovoltaic (TFPV) solar cell technologies and manufacturing processes, announced the company completed the development of a co-evaporation processing chamber design that combines several thermal evaporation techniques in one unified process to produce the CIGS (Copper Indium Gallium diSelenide) solar cell`s absorber layer. This is a major milestone for the company, as the chamber plays a crucial role in XSNXs ability to viably produce commercial quantities of CIGS solar cells using small-area processing techniques. Shares of XSNX closed at $0.1555, up $0.0255, or 19.6%.

IceWEB, Inc(OTCBB: IWEB), a leading provider of purpose built appliances and building blocks for cloud storage networks, announced that the company has received an award to assist the U.S. Department of Homeland Security with a remote sensing storage solution. The multi-terabyte system will be deployed in the current quarter. The company also announced that it has successfully integrated AES-256 Encryption, an encryption standard adopted by the U.S. Government, at the folder level within its Iplicity product line. IceWEB will also be opening an office in Austin, TX as part of the companys efforts to expand its Channel Network Program (CNP), which offers increased support to address high-value markets, including government, energy, manufacturing, Internet and cloud, financial services, digital media, and K-12 education, and meet the ever-growing customer requirements for Cloud Computing and enterprise solutions. IWEB has also signed on storage veterans to run the Central, South-Central, Southeast and Mountain geographic regions covered in its CNP. The company reports that data storage and cloud computing industries are providing returns not seen since the late 1990s, and showing no signs of slowing down. Shares of IWEB closed at $0..158, down $0.012, or 7.1% OmniComm Systems, Inc. (OTCBB: OMCM),a global provider of eClinical solutions, announced that a leading cardiovascular medical device manufacturer has renewed its contract with the company for another 5 years. The agreement extends and expands the previous five-year agreement which generated over $2.5 Million in revenue for the company over the past three years. The company expects revenue for this customer to increase. Shares of OMCM remained unchanged at $0.20.

ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC)announced last week that its dendritic cell-based vaccination with cancer stem cells (CSCs) demonstrated a statistically significant survival benefit in a preclinical animal model of glioblastoma. The rats were either immunized with cancer stem cells (CSCs) from a brain cancer tumor or the daughter cells (the bulk of the tumor), and results showed that those immunized with the CSCs had a median survival of 50 days compared to 29 days for daughter cells. Furthermore, 30% of animals vaccinated against cancer stem cells demonstrated long term survival as compared to animals vaccinated with the bulk of the tumor, all of which died. Shares of IMUC closed at $1.00, up $0.10, or 11.1%.

Resort and Residence TV Inc., a Wholly Owned Subsidiary of Next One Interactive Inc. (OTCBB: NXOI), announced a new distribution agreement with Capital Broadcasting to expand viewership. The first Capital Broadcasting launch of Resort and Residence TV will begin delivering its full time programming network during the week of March 15th in the Los Angeles market on channel 45 reaching 3.1 million homes. Within 30 days of this initial launch of the LA market, Capital Broadcasting plans to deliver Resort and Residence TV on its other stations including San Diego Channel 43 and Austin Texas Channel 11. The company also announced it will begin streaming its full time television programming network online, enabling consumers anywhere to access the programming content through the web. Shares of NXOI closed at $0.69, up $0.03, or 4.5%.

Sparta Commercial Services, Inc. (OTCBB: SRCO),in following up on its strategic agreement with Armet Armored Vehicles, a global leader in the manufacturing of tactical armored and other specialty vehicles for governmental and other markets, reported a potential annual $5 million in Municipal Lease Purchase agreements generated from this relationship. Armet Armored Vehicles has chosen Sparta Commercial Services as the primary sales and financing option for Municipal Lease Purchases by local, county, and state governmental agencies that acquire specialty vehicles from Armet. Shares of SRCO closed at $0.021, down $0.009, or 30%.

A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. THE READER SHOULD VERIFY ALL CLAIMS AND DO ITS OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. This publication accepts compensation from companies that it features. This newsletter should not be regarded as an independent publication. Our editors may, from time to time, acquire positions in the companies that they cover. This could represent a conflict of interest. The CEOcast newsletter shall be under no obligation to inform readers about its trading activities. CEOcast`s editors reserve the right to buy or sell shares in these companies at any time. The following companies, featured in this newsletter, have compensated CEOcast: Advanced Cell Technology, seven thousand five hundred dollars per month, plus warrants to purchase up to fifteen million shares of stock; iceWEB, seven thousand five hundred dollars per month in cash, plus seven thousand five hundred dollars in stock per month for a six-month agreement; PHC, seven thousand five hundred dollars per month; Money4Gold, ten thousand dollars per month and four hundred thousand shares for a six-month agreement; Hythiam, ten thousand dollars per month and two hundred fifty thousand shares for a one-year agreement; NewCardio, seven thousand five hundred dollars per month and two hundred thousand shares of stock for a six-month agreement; ImmunoCellular Therapeutics, twelve thousand five hundred dollars per month; CEL SCI Corporation,five thousanddollars andthree hundred fiftythousand shares of stock for a one-year program; OmniComm, thirteen thousand six hundred and fifty dollars per month, payable in cash and common stock for a one year agreement; Next One Interactive, fifteen thousand dollars per month, payable in cash and common stock for a one year agreement; Sparta Commercial, twelve thousand five hundred dollars per month through a combination of cash and stock; XsunX, Thirteen thousand seven hundred fifty dollars per month through a combination of cash and stock; Enzo Biochem, seventeen thousand dollars per month.

UNSUBSCRIBE You can either

ACTC · CIGS · HYTM · IMUC · IWEB · MFGD · NWCI · NXOI · OMCM · SHBI · SRCO · XSNX